首页 | 本学科首页   官方微博 | 高级检索  
     


Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features
Authors:Vogrig  Alberto  Gigli  Gian Luigi  Nilo   Annacarmen  Pessa   Maria Elena  Volpetti   Stefano  Pegolo   Enrico  Valente   Mariarosaria
Affiliation:1.Clinical Neurology Unit, Santa Maria della Misericordia University Hospital, Piazzale Santa Maria della Misericordia, 15, 33010, Udine, Italy
;2.Neurology Unit, Department of Medicine, University of Udine Medical School, Udine, Italy
;3.Department of Mathematics, Informatics and Physics (DMIF), University of Udine, Udine, Italy
;4.Hematology and Cellular Therapy Unit, University Hospital Santa Maria della Misericordia, Udine, Italy
;5.Institute of Pathology, Department of Medicine, University of Udine Medical School, Udine, Italy
;
Abstract:Journal of NeuroVirology - Idelalisib, a selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor, is a newly approved second-line drug for patients with chronic lymphocytic leukemia....
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号